{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:35:23Z","timestamp":1792100123458,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinical-colorectal-cancer.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.clcc.2024.04.002","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T02:33:00Z","timestamp":1712716380000},"page":"135-146.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Complete Obstruction, a Real Risk Factor: A Comprehensive Study on Obstruction in Stage IIA Colon Cancer With Propensity Score Matching Analysis"],"prefix":"10.1016","volume":"23","author":[{"given":"Soo Young","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2382-0939","authenticated-orcid":false,"given":"Chan Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Lyul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Sik","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Ja","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Byung","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Sik","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clcc.2024.04.002_bib0001","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00000658-198312000-00013","article-title":"The prognostic significance of tumor location and bowel obstruction in Dukes B and C colorectal cancer. Findings from the NSABP clinical trials","volume":"198","author":"Wolmark","year":"1983","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.clcc.2024.04.002_bib0002","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/bjs.1800720417","article-title":"Malignant large bowel obstruction","volume":"72","author":"Phillips","year":"1985","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.clcc.2024.04.002_bib0003","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/bjs.5269","article-title":"The impact of blood loss, obstruction and perforation on survival in patients undergoing curative resection for colon cancer","volume":"93","author":"McArdle","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.clcc.2024.04.002_bib0004","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1245\/s10434-011-1625-3","article-title":"Prognostic significance of preoperative bowel obstruction in stage III colorectal cancer","volume":"18","author":"Katoh","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.clcc.2024.04.002_bib0005","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.amjsurg.2003.12.028","article-title":"Long-term prognosis of patients with obstructing carcinoma of the right colon","volume":"187","author":"Wang","year":"2004","journal-title":"Am J Surg"},{"issue":"1","key":"10.1016\/j.clcc.2024.04.002_bib0006","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/SLA.0000000000003832","article-title":"Is adjuvant chemotherapy necessary for obstructing stage II colon cancer? Results from a propensity score analysis of the French Surgical Association Database","volume":"275","author":"Sabbagh","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.clcc.2024.04.002_bib0007","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s10147-018-1307-2","article-title":"Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer","volume":"23","author":"Okuda","year":"2018","journal-title":"Int J Clin Oncol"},{"issue":"7225","key":"10.1016\/j.clcc.2024.04.002_bib0008","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/457036b","article-title":"Inflaming metastasis","volume":"457","author":"Mantovani","year":"2009","journal-title":"Nature"},{"issue":"7203","key":"10.1016\/j.clcc.2024.04.002_bib0009","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.clcc.2024.04.002_bib0010","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/codi.15479","article-title":"Definition of large bowel obstruction by primary colorectal cancer: a systematic review","volume":"23","author":"Veld","year":"2021","journal-title":"Colorectal Dis"},{"issue":"1","key":"10.1016\/j.clcc.2024.04.002_bib0011","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3393\/ac.2019.03.10.1","article-title":"Surgical risk and pathological results of emergency resection in the treatment of acutely obstructing colorectal cancers: a retrospective cohort study","volume":"37","author":"Tebala","year":"2021","journal-title":"Ann Coloproctol"},{"issue":"3","key":"10.1016\/j.clcc.2024.04.002_bib0012","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3393\/ac.2020.01067.0152","article-title":"Comparison of the oncological outcomes of stenting as a bridge to surgery and surgery alone in stages II to III obstructive colorectal cancer: a retrospective study","volume":"38","author":"Uehara","year":"2022","journal-title":"Ann Coloproctol"},{"issue":"1","key":"10.1016\/j.clcc.2024.04.002_bib0013","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3393\/ac.2021.00227.0032","article-title":"Comparison of long-term outcomes of colonic stenting as a \u201cbridge to surgery\u201d and emergency surgery in patients with left-sided malignant colonic obstruction","volume":"39","author":"Khomvilai","year":"2023","journal-title":"Ann Coloproctol"},{"issue":"3","key":"10.1016\/j.clcc.2024.04.002_bib0014","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3393\/ac.2022.00101.0014","article-title":"Short-and long-term outcomes of subtotal\/total colectomy in the management of obstructive left colon cancer","volume":"39","author":"Son","year":"2023","journal-title":"Ann Coloproctol"},{"issue":"3","key":"10.1016\/j.clcc.2024.04.002_bib0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/jso.2930470310","article-title":"Prognostic factors in Japanese patients with colorectal cancer: the significance of large bowel obstruction\u2014univariate and multivariate analyses","volume":"47","author":"Korenaga","year":"1991","journal-title":"J Surg Oncol"},{"issue":"2","key":"10.1016\/j.clcc.2024.04.002_bib0016","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0959-8049(95)00532-3","article-title":"Survival for colon and rectal cancer in a population-based cancer registry","volume":"32","author":"Roncucci","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clcc.2024.04.002_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.914299","article-title":"Comparison of oncologic outcomes between incomplete obstructive colon cancer and non-obstructive colon cancer by tumor location","volume":"12","author":"Lim","year":"2022","journal-title":"Front Oncol"},{"issue":"9604","key":"10.1016\/j.clcc.2024.04.002_bib0018","first-page":"2020","article-title":"Comparison of oncologic outcomes between incomplete obstructive colon cancer and non-obstructive colon cancer by tumor location","volume":"370","author":"Group","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.clcc.2024.04.002_bib0019","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1200\/JCO.2015.63.4238","article-title":"Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study","volume":"33","author":"Andr\u00e9","year":"2015","journal-title":"J Clin Oncol"},{"issue":"28","key":"10.1016\/j.clcc.2024.04.002_bib0020","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1200\/JCO.2011.36.4539","article-title":"Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses","volume":"29","author":"Yothers","year":"2011","journal-title":"J Clin Oncol"},{"issue":"25","key":"10.1016\/j.clcc.2024.04.002_bib0021","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1200\/JCO.2010.34.3426","article-title":"Adjuvant chemotherapy for stage II colon cancer with poor prognostic features","volume":"29","author":"O'Connor","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2024.04.002_bib0022","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1245\/s10434-014-3982-1","article-title":"Survival paradox between stage IIB\/C (T4N0) and stage IIIA (T1-2N1) colon cancer","volume":"22","author":"Kim","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2024.04.002_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-016-2446-3","article-title":"Poor survival in stage IIB\/C (T4N0) compared to stage IIIA (T1-2 N1, T1N2a) colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapy","volume":"16","author":"Chu","year":"2016","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.clcc.2024.04.002_bib0024","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/jso.25515","article-title":"Clinicopathological and biomolecular characteristics of stage IIB\/IIC and stage IIIA colon cancer: insight into the survival paradox","volume":"120","author":"Kim","year":"2019","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clcc.2024.04.002_sbref0025","series-title":"Statement on ASA Physical Status Classification System","year":"2014"},{"key":"10.1016\/j.clcc.2024.04.002_bib0026","unstructured":"Association WM. WMA Declaration of Helsinki\u2013Ethical Principles For Medical Research Involving Human Subjects. 2022; Accessed: November 18, 2023, https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/."},{"issue":"1","key":"10.1016\/j.clcc.2024.04.002_bib0027","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11605-022-05516-5","article-title":"Prognostic implications of endoscopic obstruction in patients with pathological stage II colon cancers: a single-center retrospective cohort study","volume":"27","author":"Mo","year":"2023","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.clcc.2024.04.002_bib0028","doi-asserted-by":"crossref","first-page":"7965","DOI":"10.4238\/2014.September.29.10","article-title":"No difference of complete or incomplete left-sided malignant colonic obstruction on both short-and long-term outcomes","volume":"13","author":"Liu","year":"2014","journal-title":"Genet Mol Res"},{"issue":"19","key":"10.1016\/j.clcc.2024.04.002_bib0029","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","article-title":"Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial","volume":"27","author":"Andr\u00e9","year":"2009","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.clcc.2024.04.002_bib0030","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1200\/JCO.2004.09.059","article-title":"Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?","volume":"22","author":"Gill","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2024.04.002_bib0031","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1245\/ASO.2006.07.003","article-title":"Current issues in adjuvant treatment of stage II colon cancer","volume":"13","author":"Andre","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2024.04.002_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.595107","article-title":"Re-evaluation of the survival paradox between stage IIB\/IIC and stage IIIA colon cancer","volume":"10","author":"Li","year":"2020","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.clcc.2024.04.002_bib0033","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/ijc.25481","article-title":"Sex disparities in colorectal cancer incidence by anatomic subsite, race and age","volume":"128","author":"Murphy","year":"2011","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.clcc.2024.04.002_bib0034","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/bjc.1998.682","article-title":"Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer","volume":"78","author":"Chapman","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clcc.2024.04.002_bib0035","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1245\/s10434-016-5748-4","article-title":"Prognostic and oncologic significance of perineural invasion in sporadic colorectal cancer","volume":"24","author":"Alotaibi","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.clcc.2024.04.002_bib0036","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/DCR.0000000000002219","article-title":"Clinical implication of perineural and lymphovascular invasion in rectal cancer patients who underwent surgery after preoperative chemoradiotherapy","volume":"65","author":"Kim","year":"2022","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clcc.2024.04.002_bib0037","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1245\/s10434-013-2919-4","article-title":"Elevation of preoperative s-CEA concentration in stage IIA colorectal cancer can also be a high risk factor for stage II patients","volume":"20","author":"Kim","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2024.04.002_bib0038","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejca.2016.07.013","article-title":"The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients","volume":"66","author":"Mol","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clcc.2024.04.002_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1194718","article-title":"The prognostic value of Eastern Cooperative Oncology Group performance status on overall survival among patients with metastatic prostate cancer: a systematic review and meta-analysis","volume":"13","author":"Assayag","year":"2023","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2024.04.002_bib0040","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ygyno.2007.08.088","article-title":"The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer","volume":"108","author":"Carey","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"15","key":"10.1016\/j.clcc.2024.04.002_bib0041","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1200\/JCO.2003.05.062","article-title":"Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089","volume":"21","author":"Le Voyer","year":"2003","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clcc.2024.04.002_bib0042","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/cncr.29072","article-title":"Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer","volume":"121","author":"Kumar","year":"2015","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.clcc.2024.04.002_bib0043","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2021.0012","article-title":"Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Benson","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"16","key":"10.1016\/j.clcc.2024.04.002_bib0044","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1200\/JCO.2004.03.087","article-title":"Adjuvant therapy for stage II colon cancer: a systematic review from the cancer care Ontario program in evidence-based care's gastrointestinal cancer disease site group","volume":"22","author":"Figueredo","year":"2004","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.clcc.2024.04.002_bib0045","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","article-title":"Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Argil\u00e9s","year":"2020","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.clcc.2024.04.002_bib0046","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1200\/JCO.21.02538","article-title":"Adjuvant therapy for stage II colon cancer: ASCO guideline update","volume":"40","author":"Baxter","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2024.04.002_bib0047","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1245\/s10434-009-0881-y","article-title":"Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials","volume":"17","author":"Wilkinson","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2024.04.002_bib0048","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10350-008-9246-z","article-title":"Identification of patients with high-risk stage II colon cancer for adjuvant therapy","volume":"51","author":"Quah","year":"2008","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"10.1016\/j.clcc.2024.04.002_bib0049","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3393\/ac.2020.00829.0118","article-title":"Effect of adjuvant chemotherapy on elderly stage II high-risk colorectal cancer patients","volume":"37","author":"Lee","year":"2021","journal-title":"Ann Coloproctol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002824000288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002824000288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T12:53:15Z","timestamp":1717332795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002824000288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1533002824000288"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2024.04.002","relation":{},"ISSN":["1533-0028"],"issn-type":[{"value":"1533-0028","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complete Obstruction, a Real Risk Factor: A Comprehensive Study on Obstruction in Stage IIA Colon Cancer With Propensity Score Matching Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2024.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}